3
Announcements
Trials
Browse
Landscape
Status
Recruiting
1
Sponsor Class
OTHER
1
Study Type
Interventional
11
Observational
1
Sponsor
Cancer Type
Thoracic
1
Head & Neck
1
Genitourinary
1
Gastrointestinal
1
CNS
1
Breast
1
Conditions
Breast Neoplasms
21
Head and Neck Neoplasms
17
Prostatic Neoplasms
15
Neoplasms
12
Lung Neoplasms
12
Radiation Injuries
9
Esophageal Neoplasms
8
Rectal Neoplasms
7
Glioma
7
Brain Neoplasms
7
Glioblastoma
6
Carcinoma, Non-Small-Cell Lung
6
Uterine Cervical Neoplasms
5
Squamous Cell Carcinoma of Head and Neck
5
Neoplasm Metastasis
5
Carcinoma, Hepatocellular
4
Stomach Neoplasms
3
Colorectal Neoplasms
3
Central Nervous System Neoplasms
3
Astrocytoma
3
Xerostomia
2
Urinary Bladder Neoplasms
2
Small Cell Lung Carcinoma
2
Sarcoma
2
Salivary Gland Neoplasms
2
Pelvic Neoplasms
2
Osteoradionecrosis
2
Lymphedema
2
Kidney Neoplasms
2
Esthesioneuroblastoma, Olfactory
2
Interventions
Hepatectomy
10
Blood Specimen Collection
9
Sorafenib
7
Polymerase Chain Reaction
4
Biopsy
4
regorafenib
3
Mass Spectrometry
3
Liver Transplantation
3
Immunohistochemistry
3
Chemoembolization, Therapeutic
3
Walking Speed
2
Surveys and Questionnaires
2
Psychiatric Rehabilitation
2
Magnetic Resonance Imaging
2
Gene Expression Profiling
2
Bevacizumab
2
trastuzumab deruxtecan
1
taxane
1
spartalizumab
1
sintilimab
1
lenvatinib
1
gadolinium ethoxybenzyl DTPA
1
donafenib
1
carmofur
1
camrelizumab
1
cabozantinib
1
atezolizumab
1
apatinib
1
anlotinib
1
Yttrium-90
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Observational
×
Liver Neoplasms
×
Radiotherapy
×
Clear all
NCT04075305
2026-03-05
MOMENTUM
UMC Utrecht
Recruiting
8,000 enrolled